Anti-infarction molecules

Details for Australian Patent Application No. 2003209030 (hide)

Owner Vicor Technologies, Inc.

Inventors Skinner, James E; Anchin, Jerry M

Agent Griffith Hack

Pub. Number AU-B-2003209030

PCT Number PCT/US03/03614

PCT Pub. Number WO2003/065997

Priority 60/429,278 25.11.02 US; 60/354,678 06.02.02 US; 60/392,133 28.06.02 US

Filing date 5 February 2003

Wipo publication date 2 September 2003

Acceptance publication date 5 February 2009

International Classifications

A61K 35/12 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

A61K 35/14 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Blood

A61K 35/16 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Plasma

A61K 35/22 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Urine

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/36 (2006.01) Medicinal preparations containing peptides - Blood coagulation or fibrinolysis factors

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 1/26 (2006.01) General processes for the preparation of peptides

C07K 5/103 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/107 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 7/18 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/575 (2006.01) Peptides having more than 20 amino acids

C07K 14/745 (2006.01) Peptides having more than 20 amino acids

G01N 33/94 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving narcotics

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 60/429,278 25.11.02 US; 60/354,678 06.02.02 US; 60/392,133 28.06.02 US

25 September 2003 Application Open to Public Inspection

  Published as AU-B-2003209030

5 February 2009 Application Accepted

  Published as AU-B-2003209030

6 August 2009 Standard Patent Sealed

16 December 2010 Assignment Registered

  Vicor Technologies, Inc. The patent has been assigned to Stasys Technologies, Inc.

30 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003209031-MICROMACHINED GYROSCOPE

2003209029-FLOWING FLUID ACOUSTIC COUPLING